Validation of serum cystatin SN detection for diagnosis and poor prognosis of esophageal squamous cell carcinoma
BackgroundThe identification of effective tumor markers is of paramount importance for the early diagnosis, treatment, and prognosis of esophageal squamous cell carcinoma (ESCC). The present study endeavors to identify efficacious serological markers that can differentiate patients with early-stage...
Main Authors: | Yingqi Pi, Sizhuo Lin, Xiuqin Ren, Lin Wang, Yiling Song, Zhikun Wu, Yanzhen Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1337707/full |
Similar Items
-
Upregulation of IBSP Expression Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma
by: Mingyue Wang, et al.
Published: (2019-10-01) -
Cystatin SN (CST1) as a Novel Salivary Biomarker of Periodontitis
by: Federica Romano, et al.
Published: (2023-09-01) -
Diagnosis and management of nonallergic rhinitis with eosinophilia syndrome using cystatin SN together with symptoms
by: Yifan Meng, et al.
Published: (2020-07-01) -
Retracted: Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma
by: Jiaojiao Ding, et al.
Published: (2021-08-01) -
INHBA upregulation correlates with poorer prognosis in patients with esophageal squamous cell carcinoma
by: Lyu S, et al.
Published: (2018-06-01)